Developing bacteria to help stop malaria transmission by mosquitoes
Toward field-ready paratransgenesis for malaria: bacterial strain optimization and microbiota interactions
['FUNDING_U01'] · DUQUESNE UNIVERSITY · NIH-11127013
This study is looking at how specially designed bacteria can help stop mosquitoes from spreading malaria to people, making it a friendly addition to current ways we fight the disease, like using insecticides and medicines.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUQUESNE UNIVERSITY (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11127013 on ClinicalTrials.gov |
What this research studies
This research focuses on creating genetically engineered bacteria that can reduce the ability of mosquitoes to transmit malaria parasites to humans. By optimizing specific bacterial strains and studying their interactions with mosquito microbiota, the researchers aim to develop effective biological control methods. The approach involves ensuring that these bacteria do not carry antibiotic resistance genes and can effectively deliver proteins that inhibit malaria transmission. This innovative method seeks to complement existing malaria control strategies, such as insecticides and medications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in malaria-endemic regions, particularly in Africa, where the disease poses a significant health risk.
Not a fit: Patients who do not live in malaria-endemic areas or those who are not at risk of malaria infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce malaria transmission rates, potentially saving countless lives and improving public health.
How similar studies have performed: Other research has shown promise in using genetically modified organisms for vector control, indicating that this approach could be viable.
Where this research is happening
PITTSBURGH, UNITED STATES
- DUQUESNE UNIVERSITY — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LAMPE, DAVID J — DUQUESNE UNIVERSITY
- Study coordinator: LAMPE, DAVID J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.